Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7736)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 8, 2017 (publication date) through Mar 29, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Corey KE, Gawrieh S, deLemos AS, Zheng H, Scanga AE, Haglund JW, Sanchez J, Danford CJ, Comerford M, Bossi K, Munir S, Chalasani N, Wattacheril J. Risk factors for hepatocellular carcinoma in cirrhosis due to nonalcoholic fatty liver disease: A multicenter, case-control study. World J Hepatol 2017; 9(7): 385-390 [PMID: 28321274 DOI: 10.4254/wjh.v9.i7.385] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v9/i7/385.htm |
| Number | Citing Articles |
| 1 |
Luis Calzadilla Bertot, Leon A Adams. Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 2019; 13(2): 179 doi: 10.1080/17474124.2019.1549989
|
| 2 |
Gian Piero Guerrini, Domenico Pinelli, Elena Marini, Vittorio Corno, Michela Guizzetti, Marco Zambelli, Alessandro Aluffi, Lisa Lincini, Stefano Fagiuoli, Alessandro Lucianetti, Michele Colledan. Value of HCC-MELD Score in Patients With Hepatocellular Carcinoma Undergoing Liver Transplantation. Progress in Transplantation 2018; 28(1): 63 doi: 10.1177/1526924817746686
|
| 3 |
Muhammad Imran Ahmad, Muhammad Umair Khan, Sudha Kodali, Akshay Shetty, S Michelle Bell, David Victor. Hepatocellular Carcinoma Due to Nonalcoholic Fatty Liver Disease: Current Concepts and Future Challenges. Journal of Hepatocellular Carcinoma 2022; : 477 doi: 10.2147/JHC.S344559
|
| 4 |
James A Thomas, Bradley J Kendall, Hashem B El-Serag, Aaron P Thrift, Graeme A Macdonald. Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease. The Lancet Gastroenterology & Hepatology 2024; 9(2): 159 doi: 10.1016/S2468-1253(23)00275-3
|
| 5 |
Ann Robinson, Ajay Ohri, Benny Liu, Taft Bhuket, Robert J Wong. One in five hepatocellular carcinoma patients in the United States are Hispanic while less than 40% were eligible for liver transplantation. World Journal of Hepatology 2018; 10(12): 956-965 doi: 10.4254/wjh.v10.i12.956
|
| 6 |
Brittany Dewdney, Alexandra Roberts, Liang Qiao, Jacob George, Lionel Hebbard. A Sweet Connection? Fructose’s Role in Hepatocellular Carcinoma. Biomolecules 2020; 10(4): 496 doi: 10.3390/biom10040496
|
| 7 |
Amanda Chaney. Obesity and Nonalcoholic Fatty Liver Disease. Nursing Clinics of North America 2021; 56(4): 543 doi: 10.1016/j.cnur.2021.07.009
|
| 8 |
Masayuki Ueno, Haruhiko Takeda, Atsushi Takai, Hiroshi Seno. Risk factors and diagnostic biomarkers for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: Current evidence and future perspectives. World Journal of Gastroenterology 2022; 28(27): 3410-3421 doi: 10.3748/wjg.v28.i27.3410
|
| 9 |
Kamyar Asadipooya, Kamran B. Lankarani, Rishi Raj, Mohammadreza Kalantarhormozi. RAGE is a Potential Cause of Onset and Progression of Nonalcoholic Fatty Liver Disease. International Journal of Endocrinology 2019; 2019: 1 doi: 10.1155/2019/2151302
|
| 10 |
Eduardo Vilar-Gomez, Luis Calzadilla-Bertot, Vincent Wai-Sun Wong, Marlen Castellanos, Rocio Aller-de la Fuente, Mohammed Eslam, Grace Lai-Hung Wong, Jacob George, Manuel Romero-Gomez, Leon A. Adams. Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Nonalcoholic Steatohepatitis–Related, Child–Pugh A Cirrhosis. Clinical Gastroenterology and Hepatology 2021; 19(1): 136 doi: 10.1016/j.cgh.2020.04.083
|
| 11 |
Eduardo Fassio, Fernando J Barreyro, M Soledad Pérez, Diana Dávila, Graciela Landeira, Gisela Gualano, Gabriela Ruffillo. Hepatocellular carcinoma in patients with metabolic dysfunction-associated fatty liver disease: Can we stratify at-risk populations?. World Journal of Hepatology 2022; 14(2): 354-371 doi: 10.4254/wjh.v14.i2.354
|
| 12 |
Teerha Piratvisuth, Tawesak Tanwandee, Satawat Thongsawat, Wattana Sukeepaisarnjaroen, Juan Ignacio Esteban, Marta Bes, Bruno Köhler, Ying He, Magdalena Swiatek‐de Lange, David Morgenstern, Henry Lik‐Yuen Chan. Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case‐Control Study. Hepatology Communications 2022; 6(4): 679 doi: 10.1002/hep4.1847
|
| 13 |
Shiyu Xiao, Ya Liu, Xiliang Fu, Tong Chen, Wenhui Xie. Modifiable Risk Factors for Hepatocellular Carcinoma in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-Analysis. The American Journal of Medicine 2024; 137(11): 1072 doi: 10.1016/j.amjmed.2024.06.031
|